应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
GRCL 亘喜生物
停牌 05-06 16:33:32 EDT
10.25
+0.00
0.00%
最高
10.25
最低
10.25
成交量
0.00
今开
10.25
昨收
10.25
日振幅
0.00%
总市值
9.91亿
流通市值
3.41亿
总股本
9,671万
成交额
6,573万
换手率
0.00%
流通股本
3,328万
市净率
4.41
ROE
-31.57%
每股收益
-0.95
52周最高
10.44
52周最低
1.40
市盈率
-10.79
股息
0.00
股息收益率
0.00
ROA
-19.41%
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
暂无数据
公司概况
公司名称：
亘喜生物
所属市场：
NASDAQ
上市日期：
2021-01-08
主营业务：
亘喜生物科技公司是一家获豁免的有限责任公司，于2018年5月22日在开曼群岛注册成立,是一家致力于发现和开发突破性细胞疗法的全球临床阶段生物制药公司。利用其开创性FasTCAR和TruUCAR技术平台，亘喜生物正在开发多项自体和同种异体的丰富临床阶段癌症治疗产品管线。这些产品有望攻克传统CAR-T疗法持续存在的重大行业挑战，包括生产时间长、产品细胞质量欠佳、治疗成本高和对实体瘤缺乏有效治疗等。
发行价格：
19.00
{"stockData":{"symbol":"GRCL","market":"US","secType":"STK","nameCN":"亘喜生物","latestPrice":10.25,"timestamp":1708549200000,"preClose":10.25,"halted":3,"volume":0,"delay":0,"floatShares":33278469,"shares":96712353,"eps":-0.950223,"marketStatus":"停牌","change":0,"latestTime":"05-06 16:33:30 EDT","open":10.25,"high":10.25,"low":10.25,"amount":65729813.680143006,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.950223,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1746576000000},"marketStatusCode":4,"adr":0,"adrRate":5,"listingDate":1610082000000,"exchange":"NASDAQ","adjPreClose":10.25,"volumeRatio":0},"requestUrl":"/m/hq/s/GRCL","defaultTab":"news","newsList":[],"profile":{"websiteUrl":"http://www.gracellbio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.023},{"period":"1month","weight":0.1152},{"period":"3month","weight":-0.0636},{"period":"6month","weight":-0.0466},{"period":"1year","weight":0.1021},{"period":"ytd","weight":-0.0385}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"亘喜生物科技公司是一家获豁免的有限责任公司，于2018年5月22日在开曼群岛注册成立,是一家致力于发现和开发突破性细胞疗法的全球临床阶段生物制药公司。利用其开创性FasTCAR和TruUCAR技术平台，亘喜生物正在开发多项自体和同种异体的丰富临床阶段癌症治疗产品管线。这些产品有望攻克传统CAR-T疗法持续存在的重大行业挑战，包括生产时间长、产品细胞质量欠佳、治疗成本高和对实体瘤缺乏有效治疗等。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.15318},{"month":2,"riseRate":0.5,"avgChangeRate":-0.016645},{"month":3,"riseRate":0,"avgChangeRate":-0.222234},{"month":4,"riseRate":0,"avgChangeRate":-0.102647},{"month":5,"riseRate":1,"avgChangeRate":0.424463},{"month":6,"riseRate":0.666667,"avgChangeRate":0.308486},{"month":7,"riseRate":0,"avgChangeRate":-0.137509},{"month":8,"riseRate":0,"avgChangeRate":-0.193275},{"month":9,"riseRate":0.666667,"avgChangeRate":0.163579},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.023734},{"month":11,"riseRate":0.666667,"avgChangeRate":0.063859},{"month":12,"riseRate":0.333333,"avgChangeRate":0.183219}],"exchange":"NASDAQ","name":"亘喜生物","nameEN":"Gracell Biotechnologies Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亘喜生物(GRCL)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亘喜生物(GRCL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亘喜生物,GRCL,亘喜生物股票,亘喜生物股票老虎,亘喜生物股票老虎国际,亘喜生物行情,亘喜生物股票行情,亘喜生物股价,亘喜生物股市,亘喜生物股票价格,亘喜生物股票交易,亘喜生物股票购买,亘喜生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亘喜生物(GRCL)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亘喜生物(GRCL)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}